UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045983
Receipt number R000052355
Scientific Title EVUS guided wiring vs. knuckle wiring for femoropopliteal chronic total occlusive lesion
Date of disclosure of the study information 2021/11/05
Last modified on 2021/11/05 00:21:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

EVUS guided wiring vs. knuckle wiring for femoropopliteal chronic total occlusive lesion

Acronym

EPOCH study

Scientific Title

EVUS guided wiring vs. knuckle wiring for femoropopliteal chronic total occlusive lesion

Scientific Title:Acronym

EPOCH study

Region

Japan


Condition

Condition

peripheral artery disease

Classification by specialty

Cardiology Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The main purpose is to examine the short-term and long-term outcomes of new drug-eluting stents (Eluvia) in different wire routes in femoropopliteal chronic total occlusive lesions

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary patency rate (at 1 month, 6 months, 12 months, 18 months, 24 months, 36 months, 48 months, 60 months)

Key secondary outcomes

Freedom from TLR
MACLE
Wire passage route evaluated by IVUS
Degree of dissection after balloon dilation, angiographic findings, IVUS findings
Procedure time, radiation exposure, contrast medium usage
Procedure complications
Improvement of patient symptoms by Rutherford classification
Improvement of ABI


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

EVUS guided wiring

Interventions/Control_2

Knuckle wiring

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Symptomatic PAD, including restenosis after POBA
2) Obstructive lesions in the femoral popliteal artery
3) The popliteal artery contains the P1-2 segment
4) Being 20 years old or older at the time of obtaining consent
5) Chronic limb threatening ischemia (CLTI) Rutherford Classification 4

Key exclusion criteria

1) Patients with acute lower limb ischemia or acute thrombosis
2) Patients with a history of stent placement for the target blood vessel
3) Patients with non-arteriosclerotic stenosis and obstructive lesions
4) Patients who have difficulty taking antiplatelet drugs / anticoagulants
5) Chronic limb threatening ischemia (CLTI) Rutherford classification 5 or 6
6) When the doctor in charge judges that it is inappropriate
7) Cases in which blood vessels cannot be visualized with EVUS

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Keisuke
Middle name
Last name Hirano

Organization

Toyohashi Heart Center

Division name

Cardiology

Zip code

441-8530

Address

21-1, Gobutori, Oyama, Toyohashi, Aichi

TEL

0532-37-3377

Email

keisuke.hirano.sayeh@gmail.com


Public contact

Name of contact person

1st name Shinsuke
Middle name
Last name Mori

Organization

Saiseikai Yokohama City Eastern Hospital

Division name

Cardiology

Zip code

230-8765

Address

3-6-1, Shimosueyoshi, Turumi-ku, Yokohama, Kanagawa

TEL

045-576-3000

Homepage URL


Email

hello_morisun@yahoo.co.jp


Sponsor or person

Institute

Toyohashi heart center

Institute

Department

Personal name



Funding Source

Organization

Tokai Live Association

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toyohashi heart center

Address

21-1, Gobutori, Oyama, Toyohashi, Aichi

Tel

0532-37-3377

Email

thcirb@outlook.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 11 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 04 Month 01 Day

Date of IRB

2021 Year 04 Month 27 Day

Anticipated trial start date

2021 Year 04 Month 27 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter prospective study


Management information

Registered date

2021 Year 11 Month 05 Day

Last modified on

2021 Year 11 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052355